New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with different phenotypes, genetic backgrounds, and pathological states. Its clinicopathological diversity challenges the diagnostic process and the execution of clinical trials, calling for specific diagnostic biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: del Campo, Marta, Zetterberg, Henrik, Gandy, Sam, Onyike, Chiadi U, Oliveira, Fabricio, Udeh‐Momoh, Chi, Lleó, Alberto, Teunissen, Charlotte E., Pijnenburg, Yolande
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790674/
https://www.ncbi.nlm.nih.gov/pubmed/35235699
http://dx.doi.org/10.1002/alz.12643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790674/
https://www.ncbi.nlm.nih.gov/pubmed/35235699
http://dx.doi.org/10.1002/alz.12643

Ejemplares similares